Suresh Kumar Manthati

This inventor holds 24 USPTO granted patents and 16 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Xenoport, Inc., Arbor Pharmaceuticals, LLC, Glaxo Group Limited. Active years: 2007-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Suresh Kumar Manthati. Retrieved from https://idiyas.com/inventor/suresh-kumar-manthati

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 24 (Patent Applications = 16)

% Patents Active = 70.8

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 4.2

ph-index = 7

Forward Citations = 156(Granted Patents)

Location History:

Cupertino, CA (US) (2007 - 2016)
Sunnyvale, CA (US) (2011 - 2024)

Company Filing History:

Arbor Pharmaceuticals, LLC

Protagonist Therapeutics, Inc.

patents

where one patent can have more than one assignee

Years Active: 2007-2025

Loading Chart...

Areas of Expertise:

Dimethyl Fumarate

Fumaric Acid Esters

Acyloxyalkyl Carbamate

Peptide Antagonists

Levodopa Ester Prodrug

GABA Analogs

Morpholinoalkyl Compounds

Prodrugs

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12440468 - Pharmaceutical compositions of dimethyl fumarate (2025-10-14),

2. 11938111 - Pharmaceutical compositions of dimethyl fumarate (2024-03-26),

3. 11229621 - Pharmaceutical compositions of dimethyl fumarate (2022-01-25),

4. 11135296 - Pharmaceutical compositions of fumaric acid esters (2021-10-05),

5. 10576055 - Pharmaceutical compositions of dimethyl fumarate (2020-03-03),

6. 10407468 - Methods for synthesizing α4β7 peptide antagonists (2019-09-10),

7. 10179118 - Pharmaceutical compositions of dimethyl fumarate (2019-01-15),

8. 9999672 - Pharmaceutical compositions of fumaric acid esters (2018-06-19),

9. 9533941 - Methods of synthesizing a levodopa ester prodrug (2017-01-03),

10. 9353057 - Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof (2016-05-31),

11. 9302977 - Method of making monomethyl fumarate (2016-04-05),

12. 9290445 - Methods of synthesizing a levodopa ester prodrug (2016-03-22),

13. 9265748 - [object Object] (2016-02-23),

14. 9139517 - [object Object] (2015-09-22),

15. 8952006 - Morpholinoalkyl fumarate compounds, pharmaceutical compositions, and methods of use (2015-02-10),

Title: Suresh Kumar Manthati: Innovator in Pharmaceutical Compositions

Introduction

Suresh Kumar Manthati is an accomplished inventor based in Sunnyvale, CA, who has made significant contributions to the field of pharmaceuticals. With a total of 23 patents to his name, he is known for his innovative approaches to drug formulation, specifically focusing on the composition of dimethyl fumarate.

Latest Patents

Among his recent innovations, Suresh Kumar Manthati has developed pharmaceutical compositions and dosage forms of dimethyl fumarate that contain low levels of certain impurities. This work aims to improve the safety and efficacy of medications derived from this important compound, showcasing his commitment to advancing pharmaceutical science.

Career Highlights

Throughout his career, Suresh Kumar Manthati has been associated with notable companies in the pharmaceutical industry. He has contributed his expertise at Xenoport, Inc. and Arbor Pharmaceuticals, LLC, where he has played a pivotal role in the development of various pharmaceutical products. His innovative spirit and dedication have significantly impacted the success of these companies.

Collaborations

Suresh has worked alongside several prominent professionals in the field, including colleagues Stephen P Raillard and Randall A Scheuerman. These collaborations have fostered a productive environment, enabling him to push the boundaries of research and innovation in pharmaceutical formulations.

Conclusion

Suresh Kumar Manthati's work in the pharmaceutical field exemplifies the importance of innovation in enhancing drug formulations. His extensive portfolio of patents, particularly related to dimethyl fumarate, reflects his significant contributions to healthcare. With continued dedication to advancing pharmaceutical technology, he is set to inspire future generations of inventors and researchers.

Profile summary based on public USPTO records.